Skip to main content
SpringerLink
Log in

Erstes Prodrug-Stimulans als neue Therapieoption bei ADHS

  • Pharmaforum
  • Published:
DNP - Der Neurologe und Psychiater Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Pressekonferenz „Neue Perspektiven in der ADHS-Therapie“, Frankfurt, 5.9.2013; Veranstalter: Shire

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Beate Fessler

Authors
  1. Beate Fessler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fessler, B. Erstes Prodrug-Stimulans als neue Therapieoption bei ADHS. DNP 14, 69 (2013). https://doi.org/10.1007/s15202-013-0515-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15202-013-0515-x

Search

Navigation